An Unprecedented Look Into the Liver Biopsy Industry - Healthcare Trends 2018

Liver biopsy is a procedure for obtaining samples from kidney tissue for analysis. Liver biopsy is used to diagnose various liver diseases such as nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, and alcoholic liver disease. Along with the diagnosis it is also used to monitor the effect of treatment and determine whether the kidney transplant is working well or not. It consists of mainly two types; percutaneous biopsy, transjugular, and laparoscopic. In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the liver to take a tissue sample for examination.

According to the Centers for Disease Control and Prevention (CDC), 3.9 million adults were diagnosed with liver disease in the U.S.

Increasing prevalence of liver diseases and increasing number of biopsy procedures and diseases are the major drivers for the growth of the market. Furthermore, rising demand for new techniques for diagnosis of chronic and the need for better diagnostic and treatment methods drive the growth of the market. Major players in the developed countries lead the global market by offering new products and services to the developing countries and emerging economies. However, the high cost of diagnostic devices and instruments may hinder the market growth during the forecast period.

The global liver biopsy market is expected to grow at a CAGR of ~4.2% during the forecast period, 2017-2023.

Get the complete insight of the Liver Biopsy Industry here https://www.marketresearchfuture.com/sample_request/5534

Top Players in Liver Biopsy Market:

Becton, Dickinson and Company, MDxHealth, Veran medical, Medtronic, Argon Medical Devices, Inc., Mauna Kea Technologies, Boston Scientific Corporation, Intact Medical Corp., C. R. Bard, Inc., Leica Biosystems, Cook Medical, RI.MOS., Hologic, Inc., Sterylab, INRAD Inc., Fujifilm Medical Systems, and others.

Market Segmentation of Liver Biopsy Market:

The global liver biopsy market is segmented on the basis of type, indication, and end user. On the basis of the diagnosis, it is segmented into percutaneous, transjugular, and laparoscopic biopsy. On the basis of indication, it is segmented into nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, alcoholic liver disease, and others. Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.

Regional Analysis of Liver Biopsy Market:

Globally, the Americas is the largest market for liver biopsy due to increasing awareness about the importance of biopsy for the diagnosis of liver disease. In the Americas, North America is the largest market with the U.S. capturing major share followed by Canada. Additionally, extensive use of technologically advanced medical devices for diagnosis and treatment of chronic liver disease, support from the government for research & development, and high health care spending drives the market growth. Additionally, increasing patient population with liver disease, diabetes, and other risk factors for renal failure is fuelling the market growth.

Europe is the second largest market for liver biopsy whose growth is attributed to an increasing emphasis on the development of new diagnostic devices, favorable reimbursement policies, and investments in the development of new technologies for the treatment of chronic disease. Rising number of specialty services offered by various healthcare providers in Europe also accelerate the growth of the market. Additionally, rising government support for research & development, and availability of funds for research will fuel the market growth during the forecast period. As per the Lancet Liver Campaign report on liver diseases in the U.K., liver disease is the only major cause of death, which is expected to increase shortly. It also stated that use of alcohol is one of the major cause of various liver diseases among the adults. Furthermore, there is an increase in the hospital admissions for alcohol-related disease such as alcohol-related liver disease in various European nations also accelerates the market growth.
The Asia Pacific is the fastest growing liver biopsy market owing to the ever-increasing prevalence of obesity, diabetes, and rising number of liver biopsy procedures in the hospital and surgical centers.

The Middle East & Africa exhibit steady growth in the liver biopsy market due to lack of funds, unavailability of technologically advanced medical devices, and limited medical facilities. In the Middle East, the United Arab Emirates (U.A.E) is the largest market owing to the progress of healthcare industry.

Browse Complete TOC of Report @ https://www.marketresearchfuture.com/reports/liver-biopsy-market-5534

Some of Major Table of Content for Liver Biopsy Market:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
4.5 Macroeconomic Indicators

TOC Continued….!

Get Instant Discount @ https://www.marketresearchfuture.com/check-discount/5534

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.